Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study of ALTO-100 in Adults With Major Depressive Disorder (MDD)

NCT05419869 is registered in ClinicalTrials.gov with Alto Neuroscience as lead sponsor.

NCT NCT05419869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05419869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study of ALTO-100 in Adults With Major Depressive Disorder (MDD)
Lead sponsor
Alto Neuroscience
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2022
Completion date
January 26, 2023
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder